Drugmaker Eli Lilly LLY0.36%increase; green up pointing triangle has teamed up with artificial-intelligence chip designer Nvidia NVDA-2.87%decrease; red down pointing triangle to build what the ...

INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles designed ...

Eli Lilly will be building a new $3 billion manufacturing facility in Katwijk, Netherlands. In an announcement Monday, Nov. 3, the Indianapolis-based pharmaceutical company said the new site will ...

In an announcement Monday, Nov. 3, the Indianapolis-based pharmaceutical company said the new site will manufacture its weight-loss pill, orforglipron, and other oral medicines. Lilly expects to ...

Pop star Lily Allen and her ex David Harbour have reportedly put their New York City townhouse on the market just days after the singer lifted the lid on the collapse of the marriage in her new album ...

In its mission to enlighten others to the symptoms of obstructive sleep apnea (OSA), Eli Lilly is getting an assist from NBA legend Shaquille O’Neal. As the newest face of Lilly’s “Don’t Sleep On OSA” ...

Lilly Endowment Inc. has awarded a $2.5 million grant to the Indiana State Museum and Historic Sites. The grant will fund a multi-year transformation of the New Harmony State Historic Site, expected ...

Editor's note: This article has been updated to provide clarity on a head-to-head study Eli Lilly conducted on its candidate, orforglipron. A pill version under development of Novo Nordisk's (NVO) GLP ...

INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles ...

Lily Allen is so back. The singer-songwriter, known for 2000s hits like “Smile” and “The Fear,” just released her first album in seven years, West End Girl—and she’s not holding back. This not only ...

Eli Lilly & Co. raised its full-year guidance as revenue from its blockbuster weight loss and diabetes drugs beat expectations in the third quarter and it began solidifying its lead over its biggest ...